A Connecticut-based medical device company just announced that the company has entered into a strategic licensing agreement with Fin-ceramica faenza spa to market the company's hydroxyapatite patient specific implant, according to the release. Shares of Kelyniam Global Inc. (OTCPK:KLYG) are bid up on the news.
Kelyniam is a Medical Device Manufacturing company that specializes in the production of custom prosthetics utilizing computer aided design and computer aided manufacturing of advanced polymers.
The company's Engineering division is constantly working with medical professionals by allowing them to operate more effectively, improving patient care, and reducing health care cost by providing the highest quality products available with today's technology. The company is continually researching and developing new products and processes to help patients live more active and productive lives.
Traders are bullish on the news as shares are currently bid up at $0.12/share (+20.0% implied open for sellers) only 10 minutes before the opening bell. This move would be a strong follow-up from the success the stock had during Tuesdays session as shares went on to close up at $0.10/share (+4.22%)
